MercoPress, en Español

Montevideo, October 24th 2021 - 19:20 UTC

 

 

White House financial support for Merck and Johnson & Johnson to speed vaccine production

Thursday, March 4th 2021 - 08:47 UTC
Full article
J&J was contracted to deliver 200 million doses to the federal government by the end of May and roughly a billion doses globally by end-2021. Photo: Getty Images J&J was contracted to deliver 200 million doses to the federal government by the end of May and roughly a billion doses globally by end-2021. Photo: Getty Images

White House senior adviser Andy Slavitt told reporters on Tuesday that the federal government is planning to spend US$100 million to help the joint partnership between Merck & Co and rival Johnson & Johnson accelerate vaccine production.

The infusion will help J&J ramp up production of its one-shot vaccine, Slavitt said.

J&J was contracted to deliver 200 million doses to the federal government by the end of May and roughly a billion doses globally by end-2021.

Over time, we believe Merck will be able to double the capacity of Johnson & Johnson,” Slavitt said.

Biden anticipated on Tuesday that the United States will have enough vaccine supply to inoculate all adults by May.

J&J, Pfizer, and Moderna are contracted to deliver 700 million doses by mid-year between them.

Top Comments

Disclaimer & comment rules

Commenting for this story is now closed.
If you have a Facebook account, become a fan and comment on our Facebook Page!